In animal experiments, LCN expression was found to increase in the substantia nigra following injection of 6-hydroxydopamine in the medial forebrain bundle, suggesting that increased LCN2 levels may be associated with PD pathogenesis. Here, LCN2 is linked to Parkinson disease.